Seer Inc (SEER)

Currency in USD
2.210
-0.090(-3.91%)
Closed·
2.2100.000(0.00%)
·
SEER Scorecard
Full Analysis
Management has been aggressively buying back shares
SEER is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.1752.225
52 wk Range
1.5852.625
Key Statistics
Prev. Close
2.21
Open
2.19
Day's Range
2.175-2.225
52 wk Range
1.585-2.625
Volume
122.99K
Average Volume (3m)
245.57K
1-Year Change
28.49%
Book Value / Share
4.9
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SEER Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.000
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Seer Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Seer Inc Company Profile

Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Employees
134

Seer Inc Earnings Call Summary for Q2/2025

  • Seer Inc. beat Q2 2025 forecasts with EPS of -$0.33 and revenue of $4.1M, up 32% YoY, despite 2.83% after-hours stock drop
  • Company maintains full-year revenue guidance of $17-18M, expects revenue from Thermo Fisher Scientific collaboration in Q3 2025
  • Launched new products enhancing proteomics capabilities, positioning Seer as a leader in large-scale unbiased proteomics studies
  • CEO highlighted multiple customers conducting large-scale studies in 2025, emphasizing Seer's pioneering role in the field
  • Faces competitive pressure from SOMA and OLINK; execution risks for new products and partnerships remain key challenges
Last Updated: 07/08/2025, 08:36
Read Full Transcript

Compare SEER to Peers and Sector

Metrics to compare
SEER
Peers
Sector
Relationship
P/E Ratio
−1.6x−1.3x−0.5x
PEG Ratio
0.19−0.010.00
Price/Book
0.5x1.2x2.6x
Price / LTM Sales
8.0x1.8x3.3x
Upside (Analyst Target)
35.7%86.9%42.9%
Fair Value Upside
Unlock25.9%6.2%Unlock

Analyst Ratings

1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 0.000

Earnings

Latest Release
Aug 06, 2025
EPS / Forecast
-0.33 / -0.36
Revenue / Forecast
4.10M / 4.05M
EPS Revisions
Last 90 days

SEER Income Statement

People Also Watch

53.80
NXT
-4.29%
2.640
VTYX
-6.05%
30.21
CHYM
+4.57%
19.00
RELY
0.00%
12.51
SNDX
+0.24%

FAQ

What Stock Exchange Does Seer Trade On?

Seer is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Seer?

The stock symbol for Seer is "SEER."

What Is the Seer Market Cap?

As of today, Seer market cap is 129.87M.

What Is Seer's Earnings Per Share (TTM)?

The Seer EPS (TTM) is -1.39.

When Is the Next Seer Earnings Date?

Seer will release its next earnings report on 10 Nov 2025.

From a Technical Analysis Perspective, Is SEER a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Seer Stock Split?

Seer has split 0 times.

How Many Employees Does Seer Have?

Seer has 134 employees.

What is the current trading status of Seer (SEER)?

As of 12 Aug 2025, Seer (SEER) is trading at a price of 2.21, with a previous close of 2.21. The stock has fluctuated within a day range of 2.18 to 2.23, while its 52-week range spans from 1.59 to 2.63.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.